Clinical Investigation of Infections Due to Leishmanial Parasites

NCT00001169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2008-03-04

No results posted yet for this study

Summary

Mechanisms of host immune response to intracellular protozoa will be investigated in patients with naturally acquired infection employing a variety of in-vitro techniques. Both non-specific and antigen-specific humoral and cellular immune responses will be assessed. Parasites will be isolated from patients, cultivated in-vitro, and characterized. Responses to chemotherapy will be assessed parasitologically, immunologically and clinically.

Conditions

  • Leishmaniasis
  • Leishmaniasis, Visceral

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1979-12-31
Completion
2001-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00001169 on ClinicalTrials.gov